Alternatives to Dren Bio

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Biotechnology company developing novel immunotherapies for cancer.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Immunotherapy company targeting oncology and autoimmune diseases.

AI-powered platform for antibody discovery and development to create new medicines.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Global immunology company developing antibody-based therapies for severe autoimmune diseases.

Develops and commercializes novel drug candidates for oncology and immunology.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

A pharmaceutical company focused on developing novel therapies for complex diseases.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Mapping cell-cell communication at scale in human tissue.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Biotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.

AI-powered drug discovery and development platform for biologics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.